Last Posted: Apr 20, 2018
- The role of cost-effectiveness analysis in precision medicine and public health genomics.
S Grosse, CDC slide presentation, Mar 2018 - Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Cost-Effectiveness Analysis.
Jarmul Jamie et al. Circulation. Cardiovascular quality and outcomes 2018 Apr 11(4) e004171 - Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal.
Wang Shi-Yi et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Apr JCO2017765941 - Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.
Yuen Tracy et al. Applied health economics and health policy 2018 Apr - Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.
Cenin Dayna R et al. Journal of gastroenterology and hepatology 2018 Apr - Significance of Pharmacogenomics in Precision Medicine.
Cascorbi Ingolf et al. Clinical pharmacology and therapeutics 2018 May 103(5) 732-735
.png)
No hay comentarios:
Publicar un comentario